[ad_1]
US biotech company Moderna announced that the corona virus vaccine it developed did not find any complications and that an emergency use permit would be applied with a 94.1% success rate.
MADE WITH 30 THOUSAND PEOPLE
In vaccine studies with over 30,000 people, Moderna said 185 of the 196 coronavirus patients received the vaccine and 11 of them received a placebo. Thirty people among these patients were reported as severe cases. Moderna announced that the vaccine was effective in all of these thirty people.
Leading Moderna’s vaccination team, Dr. Tal Zaks said in a statement, “We believe we have an extremely effective vaccine. We now have the data to prove it,” and said, “We hope to play an important role in eradication. of this epidemic “.
“NOT A STATISTICALLY SIGNIFICANT DIFFERENCE”
Explaining the efficacy rate of 94.5% on November 16 and stating 94.1 in the figure announced today, Dr. Moderna’s coronavirus vaccine. Tal Zaks said this ratio is not a statistically significant difference.
Moderna is in the case of the second vaccine that required emergency use authorization after the Pfizer-Biontech vaccine, which required emergency use last week. The efficacy of the Pfizer-Biontech vaccine has been announced at 95%.
RESULTS OF DECEMBER 17
Independent consultants from the U.S. Food and Drug Administration will meet on December 17 to review Moderna’s vaccine studies. It was previously announced that officials would meet on December 10 to review Pfizer’s data.
Source link
